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Background: We compared demographic and clinical characteristics of early-onset sepsis (EOS) and community-acquired
late onset sepsis (CA-LOS) in infants.
Methods: Our medical center is the sole hospital in southern-Israel, enabling incidence calculations. EOS (<7 days)
and CA-LOS (7–90 days) episodes recorded between 2007 and 2013 were reviewed. Univariate and multivariate
analyses were performed.
Results: 70 EOS and 114 CA-LOS episodes were recorded. The respective mean ± SD annual rates per 1,000
live-births were 0.66 ± 0.16 and 1.03 ± 0.23. Prematurity (42.9 % vs. 17.0 %), premature rupture of membranes
(PROM; 22.9 % vs. 1.9 %), leukopenia (29.0 % vs. 11.6 %), thrombocytopenia (44.9 % vs. 14.3 %) and Streptococcus
agalactiae infections (22.7 % vs. 8.1 %) were more common in EOS. Fever (25.4 % vs. 79.1 %) and Streptococcus
pneumoniae infections (1.3 % vs. 12.9 %) were less common in EOS. In both groups, Gram-negative bacteria
predominated (~60 %). Longer hospitalization duration (23.3 ± 25.1 vs. 10.3 ± 8.6 days) and higher case fatality
rate (20.0 % vs. 5.3 %) were noted in EOS. Antibiotic resistance rates to empiric EOS and CA-LOS treatments were
0.0 % and 1.2 %, respectively.
In multivariate analysis, adjusting for prematurity and ethnicity, PROM, central line, low Apgar-score, low
birth-weight, ventilation support and non-vaginal delivery were risk factors for EOS. Normal temperature,
thrombocytopenia and leukopenia characterized EOS.
Conclusion: EOS and CA-LOS rates were low in Jewish compared with Bedouin infants. EOS was characterized by
higher rates of perinatal risk factors, S. agalactiae infections, normal temperature, thrombocytopenia, leukopenia
and mortality, while fever and S. pneumoniae infections were common in CA-LOS. Current initial antibiotic
regimens seem adequate, considering the susceptibility patterns of the isolated pathogens
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Sepsis is an important cause of morbidity and mortality
among newborn infants [1, 2]. The overall incidence of
neonatal sepsis ranges from one to 5 cases per 1,000 live
births, and case fatality rates (CFRs) range from 2 % to
60 %. Both rates depend on multiple factors, such as* Correspondence: shalomb2@clalit.org.il
1Pediatric Infectious Disease Unit, Soroka University Medical Center, P.O. Box
151, Beer-Sheva 84101, Israel
2Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva,
Israel
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zepathogen distribution, gestational age, Streptococcus aga-
lactiae (group B Streptococcus, GBS) carriage rates and
prevalence of other common specific pathogens [1, 3, 4].
Sepsis in infants is often classified as being of early
onset (EOS, 0–6 days) or late onset (LOS, 7–90 days)
[5–8]. EOS is further divided into very early onset (V-
EOS, 0–2 days) and other EOS (3–6 days), while LOS is
sometimes further divided to age groups of 7–30 days
and 31–90 days [5]. Another acceptable classification
differentiates between hospital-acquired and community-
acquired sepsis [5, 9–11].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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microbial therapy which is influenced by factors that
include, among others, the likely etiologic agent and its
known susceptibility patterns, community or hospital
acquired infection and central nervous system (CNS)
involvement [5]. EOS is more likely to be derived from
vertical acquisition of microorganisms from the mother
during labor [6], while LOS is more likely to be derived
from horizontal transmission of pathogens from the
infant's caregivers. Consequently, pathogens distribution
and risk factors for EOS and LOS differ in many aspects
[5, 6]. Moreover, risk factors for LOS are mainly defined
for hospital-acquired cases [12]. However, data regarding
risk factors and clinical manifestations of community-
acquired LOS (CA-LOS) are scarce [9, 11, 13, 14]. Never-
theless, the empiric therapy used by most clinicians for
the treatment of EOS and CA-LOS consists of penicillins
in combination with aminoglycosides [6, 7].
In a previous study, conducted 20 years ago at the
Soroka University Medical Center (SUMC), high gram-
negative and very low GBS rates in both EOS and LOS
were demonstrated [9]. The SUMC is the only hospital
providing medical care in southern Israel, and therefore
>95 % of deliveries (14,682 and 16,963 births/year in
2007 and 2013, respectively) and pediatric hospitaliza-
tions in the region take place at this institution, enabling
incidence calculations.
We hypothesized that in the last twenty years, the epi-
demiology of neonatal sepsis in southern Israel has signifi-
cantly changed.
The aim of this study was to compare risk factors,
demographic and clinical characteristics of EOS and
CA-LOS in southern Israel.
Methods
Study population and design
This was a retrospective, population-based study.
Data were derived from an ongoing prospective sur-
veillance database, monitoring all positive blood or cere-
brospinal fluid (CSF) samples from less than 90 day old
infants. The database is managed by The Pediatric Infec-
tious Disease Unit of the SUMC. Episodes of sepsis in
infants identified between 2007 and 2013 were included.
The southern region of Israel (the Negev) has a hetero-
geneous population, consisting of ~80 % Jews (represent-
ing only ~50 % of all births), who live mainly in urban
centers and a few rural communities, and 20 % Bedouin
Arabs (~50 % of all births), who are in various stages of
transition from semi-nomadism to settled modern day life.
The two groups are different in many aspects, with the
Bedouin population characterized as being of a lower
socio-economic status, with higher rate of consanguineous
marriage and fertility rate and a lesser use of prenatal care.
The SUMC is the only medical center of the region andprovides full primary and tertiary neonatal care to both
populations [9, 15].
In southern Israel, >95 % of the children are born at
the only medical center in the region. The proportion of
children born at the SUMC in each ethnic group during
the study period per year is approximately equal: 7507
Jewish children and 7174 Bedouin children, in 2013 [16].
Case definitions
Sepsis
A positive blood or CSF culture with a recognized
blood pathogen associated with appropriate clinical
findings as judged by a senior neonatologist or a pediatric
infectious disease specialist. Two successive positive blood
cultures with the same antibiotic susceptibility pattern
(in addition to appropriate clinical findings) were required
for the diagnosis of coagulase negative Staphylococcus
(CONS) infection.
EOS
An episode occurring in a newborn < 7 days old, resident
of the region, with ≥1 positive blood or CSF cultures.
EOS was divided into very early onset (V-EOS, <3 days)
and other EOS (3–6 days), we compared the risk factors,
demographic, clinical and laboratory characteristics, distri-
bution of pathogens and antibiotic susceptibility patterns
of the two subgroups.
CA-LOS
An episode occurring in a non-hospitalized infant between
the age of 7 and 90 days, resident of the region, with ≥1
positive blood or CSF cultures with a recognized blood
pathogen. A new CA-LOS episodes had to be separated
by >48 h from prior hospitalization discharge.
Meningitis
An episode with either positive bacterial CSF culture or
positive blood culture with CSF pleocytosis (defined as
>20 and >10 leukocytes/μl in infants <28 days and 28–90
days old, respectively).
Urosepsis
An episode with positive urine and blood culture for the
same pathogens.
We defined risk factors for sepsis in accordance with
those previously described [5]. The following risk factors
were considered in our study: prematurity (<37 weeks);
low birth weight (<2,000 g);premature rupture of mem-
branes >16 h (PROM); low 5-min Apgar score (<8) and
chorio-amnionitis (as defined by the treating physician).
Data collection
Medical charts were reviewed retrospectively and the
following clinical and laboratory data were extracted:
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or Bedouin), maternal age, PROM, chorio-amnionitis,
mode of delivery (vaginal, or instrumental delivery in-
cluding cesarean section and vacuum), Apgar scores,
temperature (highest and lowest recorded in the first
day of each episode), blood count, cultures results, anti-
biotic susceptibilities, duration of hospitalization and
mortality.
Identification of isolates
Blood and CSF cultures were performed at the SUMC
clinical microbiology laboratory. All blood cultures
were processed using the Bactec 9240 system (Becton
Dickinson, Franklin Lakes, NJ) and antibiotic suscepti-
bility was determined using standard procedures [17].
For each episode, only one positive culture was
accounted for. If identical bacteria were isolated simul-
taneously from blood and CSF the episode was defined
as meningitis.
Statistical analysis
Incidence was calculated as the number of episodes di-
vided by the total population at risk during each study
year. The age-specific and ethnicity-specific populations
at risk were estimated according to the Israeli Central
Bureau of Statistics reports [16]. Annual incidence rates
were calculated as numbers of sepsis episodes per 1,000
live births.Fig. 1 Flow chart of patient selectionAnalysis of contingency data was conducted by the 2-
tailed X2 test. Continuous variables were compared using
the Student’s t test. P value of <0.05 was considered statis-
tically significant.
Logistic regression models were used to evaluate po-
tential risk factors, covariate and confounders. Variables
implicated in the literature [5]: prematurity (<37 weeks);
low birth weight (<2,000 g); premature rupture of mem-
branes >16 h (PROM); low 5-min Apgar score (<8) and
chorio-amnionitis and those that were statistically sig-
nificant at the level of P < 0.1 in the univariate analyses
were included in multivariate logistic regression models.
The study was approved by the Institutional Ethics Com-
mittees of the Soroka University Medical Center (SUMC).
Results
During the study period, 558 positive blood and CSF
cultures were identified. Of those, 141 (25.3 %) were from
infants <7 days old (EOS) and 417 (74.7 %) from infants 7–
90 days old (LOS). After exclusion of hospital-acquired epi-
sodes (LOS cultures obtained >48 h post-admission), dupli-
cations and cultures considered non-clinically significant,
70 EOS episodes and 114 CA-LOS episodes were included
in the final analysis (Fig. 1). Of the 70 EOS episodes, 41
(58.6 %) occurred in the first 72 h (V-EOS), and 29 (41.4 %)
more than 72 h after birth. Of the latter, 6 (20.7 %) occurred
after hospital discharge from the newborn department. Of
the 114 CA-LOS episodes, 45 (39.5 %), 39 (34.2 %) and 30
Table 1 Demographic characteristics, risk factors and outcome of
Early Onset Sepsis (EOS) (<7 days) vs. Community-acquired Late
Onset Sepsis (CA-LOS) (7–90 days) in Southern Israel, 2007-2013
EOS CA-LOS P value
N = 70 N = 114
Male (n, %) 46 (65.7 %) 63 (55.3 %) 0.161
Female (n, %) 24 (34.3 %) 51 (44.7 %)
Jewish (n, %) 26 (37.1 %) 41 (36.0 %) 0.872
Bedouin (n, %) 44 (62.9 %) 73 (64.0 %)
Non vaginal delivery
(C/S or Vacuum)
33/70 (47.1 %) 28/112 (25.0 %) 0.002
Central line (n, %) 42/68 (61.8 %) 15/112 (13.4 %) <0.001
Mechanical ventilation (n, %) 34/70 (48.6 %) 14/112 (12.5 %) <0.001
Prematurity (<37 GA) (n, %) 30/70 (42.9 %) 19/112 (17.0 %) <0.001
Birth weight < 2000 g. (n, %) 24/70 (34.3 %) 7/111 (6.3 %) <0.001
PROM > 16 h (n, %) 16/70 (22.9 %) 2/108 (1.9 %) <0.001
Chorio-Amnionitis 8/70 (11.4 %) 0/108 (0.0 %) <0.001
Apgar score < 8 (n, %) 13/68 (19.1 %) 2/105 (1.9 %) <0.001
Mean Hospitalization
duration (days) ± SD
23.3 ± 25.1 10.3 ± 8.6 <0.001
Mortality (n, %) 14 (20.0 %) 6 (5.3 %) 0.002
C/S, cesarean section, GA, gestational age, PROM, premature rupture
of membrane
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life, respectively.
Incidence of EOS and CA-LOS (Fig. 2)
Mean (±SD) annual rates per 1,000 live births of EOS
and CA-LOS were 0.66 ± 0.16 and 1.03 ± 0.23, respect-
ively. The respective rates of V-EOS and pneumococcal
sepsis were 0.26 ± 0.13 and 0.17 ± 0.13. The rates of
EOS and CA-LOS caused by GBS were 0.17 ± 0.08 and
0.09 ± 0.04, respectively.
Non-significant declines in V-EOS, EOS, CA-LOS,
GBS and pneumococcal sepsis rates were observed
(comparing rates in 2013 vs. 2007), with respective
declines of 38 % (P = 0.38), 44 % (P = 0.20), 38 % (P =
0.13), 31 % (P = 0.55) and 83 % (P = 0.10) during the
study period.
Demographic characteristics and risk factors for EOS vs.
CA-LOS (Table 1)
Mean EOS and CA-LOS rates were higher in the
Bedouin population than in the Jewish population; 0.77
± 0.35 vs. 0.50 ± 0.29 for EOS and 1.29 ± 0.59 vs. 0.79 ±
0.32 for CA-LOS (P < 0.01, both). In contrast, mean
GBS neonatal sepsis rate did not differ significantly in
the Bedouin and the Jewish populations (0.19 ± 0.19 vs.
0.33 ± 0.08, P = 0.30).
Non-vaginal deliveries, central line exposure, mechan-
ical ventilation, prematurity, low birth weight, PROM,
chorio-amnionitis and low Apgar score were all signifi-
cantly more common in EOS compared with CA-LOS.Fig. 2 Incidence per 1,000 live births of V-EOS, EOS, CA-LOS, GBS and pneuClinical and laboratory characteristics (Table 2)
While septicemia was more common in EOS, uro-
sepsis was more common in CA-LOS and meningitis
did not differ significantly between the two.mococcal neonatal sepsis in southern Israel, 2007–2013
Table 2 Clinical Characteristics of Early Onset Sepsis (EOS)
(<7 days) vs. Community-acquired Late Onset Sepsis (CA-LOS)
(7–90 days) in Southern Israel, 2007-2013
EOS CA-LOS P value
N = 70 N = 114
Meningitis (n, %) 10/69 (14.5 %) 23/112 (20.5 %) 0.306
Uro-sepsis (n, %) 7/69 (10.1 %) 35/112 (31.2 %) 0.001
Temperature≥ 38 °C 16/63 (25.4 %) 87/110 (79.1 %) <0.001
Temperature < 36 °C 3/63 (4.8 %) 13/110 (11.8 %) 0.123
WBC > 20,000 cells/μl 14/69 (20.3 %) 36/112 (32.1 %) 0.083
WBC < 5,000 cells/μl 20/69 (29.0 %) 13/112 (11.6 %) 0.005
PMN < 1,000 cells/μl (n, %) 10/69 (14.5 %) 6/111 (5.4 %) 0.037
PLT >450,000 cells/μl (n, %) 1/69 (1.4 %) 50/112 (44.6 %) <0.001
PLT < 150,000 cells/μl (n, %) 31/69 (44.9 %) 16/112 (14.3 %) <0.001
WBC, white blood cells, PMN, polymorphonuclear, PLT, platelets
Table 3 Distribution of pathogens causing Early Onset Sepsis (EOS)
(<7 days) vs. Community-acquired Late Onset Sepsis (CA-LOS) (7–90
days) in Southern Israel, 2007-2013
EOS CA-LOS P value
N = 75a N = 124a
Gram negative 44/75 (58.7 %) 78 (62.9 %) 0.552
Escherichia coli 26/75 (34.7 %) 36/124 (29.0 %) 0.406
Klebsiella pneumoniae 10/75 (13.3 %) 9/124 (7.3 %) 0.158
Haemophilus influenzae 1/75 (1.3 %) 8/124 (6.5 %) 0.157
Pseudomonas spp. 3/75 (4.0 %) 6/124 (4.8 %) 1.000
Enterobacter cloacae 0/75 (0.0 %) 5/124 (4.0 %) 0.159
Campylobacter spp. 0/75 (0.0 %) 3/124 (2.4 %) 0.292
Neisseria meningitides 0/75 (0.0 %) 3/124 (2.4 %) 0.292
Other 4/75 (5.3 %) 8/124 (6.5 %) 1.000
Gram positive 31/75 (41.3 %) 46/124 (37.1 %) 0.552
GBS 17/75(22.7 %) 10/124 (8.1 %) 0.004
Streptococcus pneumoniae 1/75 (1.3 %) 16/124 (12.9 %) 0.005
Staphylococcus aureus 4/75 (5.3 %) 12/124 (9.7 %) 0.275
Enterococcus faecalis 7/75 (9.3 %) 6/124 (4.8 %) 0.244
Listeria monocytogenes 2/75 (2.7 %) 0/124 (0.0 %) 0.141
Streptococcus pyogenes 0/75 (0.0 %) 2/124 (1.6 %) 0.528
aIn 15 episodes (5 EOS and 10 CA-LOS episodes), mixed infection with 2 bacteria
were identified
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hypothermia <36.0° (11.8 % vs. 4.8 %, P = 0.12) were
more common in CA-LOS than in EOS.
Leukopenia <5,000/μl, neutropenia <1,000/μl and
thrombocytopenia <150,000/μl were significantly more
common in EOS, while leukocytosis > 20,000/μl was more
common in CA-LOS (32.1 % vs. 20.3 %, P = 0.083).
Distribution of pathogens (Table 3)
Overall, 199 bacteria were isolated in 184 episodes (in
15 episodes; 5 EOS and 10 CA-LOS episodes, mixed
infection with 2 bacteria were identified).
Gram-negative bacteria comprised 58.7 % and
62.9 % of all EOS and CA-LOS episodes, respectively
(P = 0.552), with Escherichia coli being the most com-
mon bacteria identified in both; 34.7 % and 29.0 % (P
= 0.406), respectively.
In central line infections, Escherichia coli com-
prised 47.6 % of EOS compared with 13.3 % of CA-
LOS (p = 0.03).
Among Gram-positive bacteria, GBS episodes were
more common in EOS compared with CA-LOS
(22.7 % vs. 8.1 %, P = 0.004). Streptococcus pneumoniae
episodes were more common in CA-LOS (12.9 %
vs.1.3 %, P = 0.005). The distribution of other bacteria
was not significantly different in both groups.Antibiotic resistance (Additional file 1, Additional file 2)
In both groups, high proportions of Gram-negative bac-
teria were resistant to penicillins; 82.9 % in EOS and
67.6 % in CA-LOS to ampicillin and 35 % to piperacillin.
None of the Gram positive EOS bacteria were resistant to
penicillins, while 18.8 % of S. pneumoniae CA-LOS epi-
sodes were resistant to penicillin. Other Gram-positive
CA-LOS episodes were all sensitive to penicillin.In 100.0 % (104/104) of EOS and CA-LOS episodes,
when tested, isolates were sensitive to amikacin, while
98.5 % (133/135) were sensitive to gentamicin. In 98.7 %
(153/155) of all episodes, isolates were sensitive to3rd
generation cephalosporins.
Episodes with extended spectrum beta lactamase (ESBL)
Gram negative bacteria were identified in 0.0 % and 1.3 %
(P = 1.0) of EOS and CA-LOS, respectively.
While no isolated bacteria were found to be resistant to
the empirical antibiotic treatment of piperacillin and amika-
cin for EOS, resistance rate to empirical CA-LOS antibiotic
treatment of ampicillin and gentamicin was detected in
1.2 % (1/90) E. coli episodes). In 4 Haemophilus influenzae
CA-LOS episodes, resistance to ampicillin was recorded,
but susceptibility to gentamicin was not evaluated.
Outcome
Mean hospitalization duration was longer (23.3 ± 25.1
vs.10.3 ± 8.6 days, P < 0.001) and case-fatality rate was
higher in the EOS group (20 % vs.5.3 %, P = 0.002). Of
the 14 EOS deaths, 11 episodes (78.8 %) were preterm
infants (7 cases were extreme preterm infants, born <28
gestational age). In 6 episodes (42.9 %) PROM was
recorded. The predominant pathogens were E. coli (8
episodes) and GBS (4 episodes).
In the 7 CA-LOS mortality cases, the predominant
pathogens were Staphylococcus aureus and S. pneumoniae
(2 episodes each).
Bulkowstein et al. BMC Pediatrics  (2016) 16:82 Page 6 of 8V-EOS (<3 days) vs. EOS during 3–6 days of age
Of the 70 EOS episodes, 41(58.6 %) were V-EOS episodes
and 29 (41.4 %) occurred in neonates >72 h of age. No
significant differences were found in most risk factors,
demographic and clinical characteristics of the two groups,
including prematurity, mean Apgar score and chorio-
amnionitis rates; sex and ethnicity; temperature and leuko-
cytes count; distribution of pathogens (excluding GBS) and
antibiotic susceptibility pattern; and case fatality rates.
However, several differences between the two groups
were observed: PROM (36.6 % vs. 3.4 %, P = 0.001) and
GBS infections (36.4 % vs. 3.2 %, P = 0.001) were more
common in V-EOS. In contrast, urosepsis (0.0 %
vs.24.1 %, P = 0.001) and thrombocytopenia (22.5 % vs.
75.9 %, P < 0.001) were less common in V-EOS.
Multivariate analysis
In a multivariate analysis adjusting for ethnicity and pre-
maturity, the significant risk factors for EOS were PROM
(OR:11.7), central-line (OR:10.9), 5 min Apgar score <8
(OR:9.9), low birth weight (OR:5.9), ventilation support
(OR:5.6) and non-vaginal delivery (OR: 2.22). A trend for
higher CFR in EOS was observed (OR: 2.8, P = 0.061)
(Table 4).
The following clinical characteristics were more common
in EOS: normal temperature (absence of hypothermia or
fever) (OR: 22.22), non-urosepsis clinical diagnosis (i.e. sep-
sis or meningitis, OR: 3.98), thrombocytopenia <150,000
cells/μl (OR: 4.43) and leukopenia <5000 cells/μl (OR:Table 4 Multivariate analysis – adjusted for ethnicity and
prematurity; odds ratio for early onset sepsis compared with
community-acquired late onset sepsis
Variable OR P value
Risk factors and
outcome
PROM (>16 h) 11.68 0.002
Central line 10.873 <0.0001
Apgar < 8 9.858 0.004
Low birth weight 5.882 <0.001
Ventilation support 5.629 <0.0001





36 °C < Fever < 38 °C 22.22 <0.0001




WBC <5,000 2.73 0.015
WBC <20,000 2.22 0.04
PROM, premature rupture of membrane, PLT, platelets, WBC, white blood cells,
OR, odds ratio2.73). In contrast, leukocytosis >20,000 cells/μl was less
common in the EOS group (OR: 2.22).
Discussion
In southern Israel, both EOS and CA-LOS rates were low
in Jewish compared with Bedouin infants. EOS was char-
acterized by higher rates of perinatal risk factors, S. aga-
lactiae infections, normal temperature, thrombocytopenia,
leukopenia and mortality. In contrast, fever and S. pneu-
moniae infections were more common in CA-LOS.
The finding of higher sepsis rates in the Bedouin popu-
lation compared with the Jewish population is similar to a
previous report from our medical center, 20 years ago [9].
In EOS, this was not related to the rate of GBS, but rather
to the rate of other pathogens, mainly Gram-negative
bacteria (E. coli and Klebsiella data not shown). This
trend may be related to higher rates of prematurity,
congenital malformations and lack of prenatal care in
the Bedouin population [15] similarly to other develop-
ing populations [18–22].
Prematurity, PROM, low birth weight, chorio-amnionitis
and low Apgar score were all more common in EOS vs.
CA-LOS, similarly to previous reports [6, 23]. This is prob-
ably due to differences in pathogenesis, where in EOS
episodes, bacteria are more likely to be acquired through
the birth canal, while in CA-LOS the mode of infec-
tion is more likely to be by direct respiratory (droplets)
and gastrointestinal contact of people surrounding the
infant [6, 11, 13, 14].
Both temperature and complete blood cells counts
(CBC) parameters differences between the two groups
point to different capability of the host (the sick infant)
to overcome infection. It is possible that neonates in
the 1st week of life are less capable of producing suffi-
cient inflammatory response, reflected in the absence
of temperature changes [24–26] and the absence of
leukocytosis [27], possibly due to immature immune
system [28–32]. This highlights the need for high de-
gree of clinical suspicion for EOS even in the absence of
temperature or CBC parameters changes. This is empha-
sized by the higher degree of disease severity (or incapabil-
ity of the host to overcome the infection), evident by the
significantly longer hospitalization duration and the higher
mortality rates in the EOS group.
The mortality rates of neonatal sepsis ranged in different
studies from 5 % to 60 %, depending upon the infecting
agent, prematurity rates and co-morbidities [5, 23, 33].
The pathogen distribution observed in our study prob-
ably reflects differences in pathogenesis. In EOS infections,
GBS and Gram-negative enteric bacteria predominated,
while in CA-LOS, the rate of pneumococcal infections
increased. Nevertheless, pathogens possibly acquired
through the birth canal (e.g. GBS), are still present in
CA-LOS. Several differences in pathogen distribution
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rates were relatively low in both the EOS and CA-LOS
groups (mean rates per 1,000 of 0.17 and 0.09, respectively)
in southern Israel compared with reports from Australia
[34], The Netherlands [35] and other industrialized coun-
tries, such as the United States (US), United Kingdom
(UK), Scotland, Northern Ireland, Germany, Finland and
Portugal [36]. These low rates are comparable to previous
reports from Israel [2, 37, 38]. Second, pneumococcal infec-
tions were common in the CA-LOS group in our study
until recent years. However, pneumococcal rates declined
in southern Israel since the year 2012, probably due to the
introduction of pneumococcal conjugate vaccines and herd
protection. Nevertheless, additional prospective studies
should be conducted to confirm this observation. Third,
Listeria infections were rare (only 2 EOS episodes through-
out the study), although high maternal colonization rates in
Israel have been previously reported [39].
These differences in pathogen distribution may be re-
lated to relatively low maternal GBS colonization rates
[2], low virulence of specific bacterial clones (e.g. GBS,
Listeria) and other unidentified environmental and epi-
demiological factors.
In contrast to other reports [5, 40], we did not find
any CONS or fungi episodes in our study. This is pre-
sumably attributed to the exclusion of all hospital-
acquired episodes in the current study and emphasizes
the concept that these pathogens are related to nosoco-
mial infections.
The current empiric treatment at the SUMC differs
in the Neonatal Intensive Care Unit (NICU) from that
administered in other settings (i.e. pediatrics wards).
All isolates in both groups were sensitive to the com-
bination of piperacillin and amikacin, which is the em-
piric treatment in our NICU. Furthermore, resistance
rate to empirical antibiotic treatment outside the NICU
setting in CA-LOS episodes (ampicillin and gentamicin)
was relatively low. In addition, ESBL positive Gram-
negative infections rates are low in our center. These
findings confirm that the current empirical treatment is
appropriate. However, it is important to notice that in
CA-LOS, considerable penicillin resistance in H. influ-
enzae and pneumococcal infections was noted.
The main limitation of our study lies in its retrospective
nature. Consequently, some data regarding risk factors are
missing (maternal GBS carriage, etc.) and we recognize
the possibility of interpreting clinical significance bias.
The study main points of strengths include its unique
ability to calculate the true incidence of infantile sepsis
in our area, as well as its ability to compare this inci-
dence between the Jewish and Bedouin populations.
Additionally, the study relatively long duration (7 years)
allows appreciation of specific pathogens rates fluctua-
tions (e.g. GBS).Conclusions
Both EOS and CA-LOS rates were low in Jewish in-
fants compared with those in Bedouin infants. EOS
was characterized by higher rates of perinatal risk
factors, S. agalactiae infections, normal temperature,
thrombocytopenia, leukopenia and mortality. In con-
trast, fever and S. pneumoniae infections were more
common in CA-LOS. Current initial antibiotic regi-
mens seem adequate, considering the susceptibility
patterns of the isolated pathogens.
Additional files
Additional file 1: Antibiotic Resistance of Pathogens Causing Early Onset
Sepsis (EOS) (<7 Days) vs. Late Onset Sepsis (7–90) In Southern Israel,
2007–2013. (DOCX 20 kb)
Additional file 2: Antibiotic susceptibilities of pathogens causing EOS
vs. CA-LOS in southern Israel, 2007–2013. (PPTX 78 kb)
Abbreviations
CA-LOS, community-acquired late onset sepsis; CBC, blood cell count; CFR,
case fatality rate; CNS, central nervous system; CONS, coagulase negative
staphylococcus; CSF, cerebrospinal fluid; EOS, early onset sepsis; ESBL,
extended spectrum beta lactamase; GBS, group B streptococcus; LOS, late
onset sepsis; NICU, neonatal intensive care unit; PROM, premature rupture
of membranes; SUMC, Soroka University Medical Center; V-EOS very early
onset sepsis
Funding
The authors did not receive funding for this study.
Availability of data and materials
The database of Soroka University Medical Center has been made available
to the authors for the purpose of this study. The individual data is
confidential and cannot be shared or made public.
Authors’ contributions
SB contributed to conception and design, acquisition, analysis, and
interpretation of data; drafted the manuscript; critically revised the
manuscript for important intellectual content; gave final approval. SB-S
contributed to conception and design, acquisition, analysis, and interpretation
of data; drafted the manuscript; critically revised the manuscript for important
intellectual content; gave final approval. NG-L contributed to analysis and
interpretation of data; critically revised the manuscript for important intellectual
content; gave final approval. RM contributed to analysis and interpretation of
data; critically revised the manuscript for important intellectual content; gave
final approval. ES contributed to analysis and interpretation of data; critically
revised the manuscript for important intellectual content; gave final approval.
DG contributed to analysis and interpretation of data; drafted the manuscript;
critically revised the manuscript for important intellectual content; gave
final approval.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
The study was approved by the Institutional Ethics Committees of the
Soroka University Medical Center (SUMC). There is no reference number.
Our manuscript does not contain any individual persons data.
Author details
1Pediatric Infectious Disease Unit, Soroka University Medical Center, P.O. Box
151, Beer-Sheva 84101, Israel. 2Faculty of Health Sciences, Ben-Gurion
University of the Negev, Beer Sheva, Israel. 3Neonatology Unit, Soroka
University Medical Center, Beer Sheva, Israel.
Bulkowstein et al. BMC Pediatrics  (2016) 16:82 Page 8 of 8Received: 3 September 2015 Accepted: 30 June 2016References
1. Edwards MS, Baker CJ. Sepsis in the newborn. In: Gershon AA, Hotez PJ, Katz
SL, editors. Krugman's Infectious Diseases of Children. 11th ed. Philadephia:
Mosby; 2004. p. 545–61.
2. Eidelman AI, Rudensky B, Turgeman D, Nubani N, Schimmel MS, Isacsohn
M. Epidemiology of group B streptococci colonization and disease in
mothers and infants: update of ongoing 10-year Jerusalem study. Isr J
Med Sci. 1990;26:71–3.
3. Bailit JL, Gregory KD, Reddy UM, Gonzalez-Quintero VH, Hibbard JU, Ramirez
MM, et al. Maternal and neonatal outcomes by labor onset type and
gestational age. Am J Obstet Gynecol. 2010;202:245. e1- e12.
4. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, et al.
The burden of invasive early-onset neonatal sepsis in the United States,
2005–2008. Pediatr Infect Dis J. 2011;30:937–41.
5. Edwards MS, Baker CJ. Bacterial infections in the neonate. In: Long SS,
Pickering LK, Prober CG, editors. Principles and Practice of Pediatric
Infectious Disease. 4th ed. Philadephia: Elsevier Saunders; 2012. p. 538–44.
6. Polin RA, The Committee on Fetus and Newborn. Management of
neonates with suspected or proven early-onset bacterial sepsis.
Pediatrics. 2012;129:1006–15.
7. Maayan-Metzger A, Barzilai A, Keller N, Kuint J. Are the "good old" antibiotics
still appropriate for early-onset neonatal sepsis? A 10 year survey. Isr Med
Assoc J. 2009;11:138–42.
8. Testoni D, Hayashi M, Cohen-Wolkowiez M, Benjamin Jr DK, Lopes RD, Clark
RH, et al. Late-onset bloodstream infections in hospitalized term infants.
Pediatr Infect Dis J. 2014;33:920–3.
9. Greenberg D, Shinwell ES, Yagupsky P, Greenberg S, Leibovitz E, Mazor M,
et al. A prospective study of neonatal sepsis and meningitis in southern
Israel. Pediatr Infect Dis J. 1997;16:768–73.
10. Didier C, Streicher MP, Chognot D, Campagni R, Schnebelen A, Messer J,
et al. Late-onset neonatal infections: incidences and pathogens in the era
of antenatal antibiotics. Eur J Pediatr. 2012;171:681–7.
11. Aggarwal R, Sarkar N, Deorari AK, Paul VK. Sepsis in the newborn. Indian J
Pediatr. 2001;68:1143–7.
12. Graham 3rd PL, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L. Risk
factors for late onset gram-negative sepsis in low birth weight infants
hospitalized in the neonatal intensive care unit. Pediatr Infect Dis J. 2006;
25:113–7.
13. Zaidi AK, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in
newborns and young infants in developing countries. Pediatr Infect Dis J.
2009;28:S10–8.
14. Waters D, Jawad I, Ahmad A, Luksic I, Nair H, Zgaga L, et al. Aetiology of
community-acquired neonatal sepsis in low and middle income countries.
J Glob Health. 2011;1:154–70.
15. Melamed Y, Bashiri A, Shoham-Vardi I, Furman B, Hackmon-Ram R, Mazor M.
Differences in preterm delivery rates and outcomes in Jews and Bedouins
in Southern Israel. Eur J Obstet Gynecol Reprod Biol. 2000;93:41–6.
16. Statistical Abstracts of Israel, 2013. No. 64. Central Bureau of Statistics.
Jerusalem: State of Israel, 2013.
17. CLSI. Performance standards for Antimicrobial Susceptibility Testing:
Twenty-Fifth Informational Supplement. CLSI document M100-S19. Wayne,
PA: Clinical and Laboratory Standards Institute; 2009.
18. Moutquin JM. Socio-economic and psychosocial factors in the management
and prevention of preterm labour. BJOG. 2003;110 Suppl 20:56–60.
19. Hammond G, Langridge A, Leonard H, Hagan R, Jacoby P, DeKlerk N, et al.
Changes in risk factors for preterm birth in Western Australia 1984–2006.
BJOG. 2013;120:1051–60.
20. Ferguson SE, Smith GN, Salenieks ME, Windrim R, Walker MC. Preterm
premature rupture of membranes. Nutritional and socioeconomic factors.
Obstet Gynecol. 2002;100:1250–6.
21. Sheridan E, Wright J, Small N, Corry PC, Oddie S, Whibley C, et al. Risk
factors for congenital anomaly in a multiethnic birth cohort: an analysis
of the Born in Bradford study. Lancet. 2013;382:1350–9.
22. Smith LK, Manktelow BN, Draper ES, Springett A, Field DJ. Nature of
socioeconomic inequalities in neonatal mortality: population based
study. BMJ. 2010;341:c6654.23. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ,
et al. Risk factors and opportunities for prevention of early-onset neonatal
sepsis: a multicenter case–control study. Pediatrics. 2000;105:21–6.
24. Bekhof J, Reitsma JB, Kok JH, Van Straaten IH. Clinical signs to identify late-
onset sepsis in preterm infants. Eur J Pediatr. 2013;172:501–8.
25. Voora S, Srinivasan G, Lilien LD, Yeh TF, Pildes RS. Fever in full-term newborns
in the first four days of life. Pediatrics. 1982;69:40–4.
26. Hofer N, Zacharias E, Muller W, Resch B. Performance of the definitions
of the systemic inflammatory response syndrome and sepsis in neonates.
J Perinat Med. 2012;40:587–90.
27. Hornik CP, Benjamin DK, Becker KC, Benjamin Jr DK, Li J, Clark RH, et al. Use
of the complete blood cell count in early-onset neonatal sepsis. Pediatr
Infect Dis J. 2012;31:799–802.
28. Hornik CP, Benjamin DK, Becker KC, Benjamin Jr DK, Li J, Clark RH, et al. Use
of the complete blood cell count in late-onset neonatal sepsis. Pediatr
Infect Dis J. 2012;31:803–7.
29. Sadeghi K, Berger A, Langgartner M, Prusa AR, Hayde M, Herkner K, et al.
Immaturity of infection control in preterm and term newborns is associated
with impaired toll-like receptor signaling. J Infect Dis. 2007;195:296–302.
30. Benitz WE, Han MY, Madan A, Ramachandra P. Serial serum C-reactive
protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102:E41.
31. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel
MS. Procalcitonin in preterm infants during the first few days of life:
introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed.
2006;91:F283–6.
32. Benitz WE. Adjunct laboratory tests in the diagnosis of early-onset neonatal
sepsis. Clin Perinatol. 2010;37:421–38.
33. Procianoy RS, Silveira RC, Mussi-Pinhata MM, Souza Rugolo LM, Leone CR, de
Andrade Lopes JM, et al. Sepsis and neutropenia in very low birth weight
infants delivered of mothers with preeclampsia. J Pediatr. 2010;157:434–8. 8 e1.
34. Ireland S, Larkins S, Kandasamy Y. Group B streptococcal infection in the
first 90 days of life in North Queensland. Aust N Z J Obstet Gynaecol. 2014;
54:146–51.
35. Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PC, Gerards LJ, Adriaanse
AH, van Lingen RA, et al. Epidemiology of neonatal group B streptococcal
disease in the Netherlands before and after introduction of guidelines for
prevention. Arch Dis Child Fetal Neonatal Ed. 2007;92:F271–6.
36. Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine.
2013;31 Suppl 4:D7–12.
37. Ginsberg GM, Eidelman AI, Shinwell E, Anis E, Peyser R, Lotan Y. Should
Israel screen all mothers-to-be to prevent early-onset of neonatal group B
streptococcal disease? A cost-utility analysis. Isr J Health Policy Res. 2013;2:6.
38. German L, Solt I, Bornstein J, Ben-Harush S, Ben-Elishai M, Weintraub Z. Is
there an increase in the incidence of GBS carrier rates among pregnant
women in northern Israel? Harefuah. 2006;145:866–9. 944.
39. Elinav H, Hershko-Klement A, Valinsky L, Jaffe J, Wiseman A, Shimon H, et al.
Pregnancy-associated listeriosis: clinical characteristics and geospatial analysis
of a 10-year period in Israel. Clin Infect Dis. 2014;59:953–61.
40. Cohen-Wolkowiez M, Moran C, Benjamin DK, Cotten CM, Clark RH, Benjamin
Jr DK, et al. Early and late onset sepsis in late preterm infants. Pediatr Infect
Dis J. 2009;28:1052–6.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
